Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of perioperative cefathiamidine prophylaxis for cesarean delivery
ChiCTR-TRC-11001853Phase 4Completed
- Sponsor
- West China Second University Hospital
- Start
- Dec 2011
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefathiamidine in post-cesarean infectious morbidity, Endomyometritis, Wound infection (WI) and 2 more (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Endomyometritis, Wound infection and 5 more. Started Dec 2011; status: completed.
02
Drugs
cefathiamidine
03
Conditions
post-cesarean infectious morbidityEndomyometritisWound infection (WI)urinary tract infection (UTI)neonatal sepsis
Beyond the preview
Go deeper on ChiCTR-TRC-11001853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001853.